Another study reported similar findings that the combination of paclitaxel and Ganoderma lucidum spores exhibited improved tumor control through recovery of the exhausted TILs by inhibiting the expressions of immune checkpoints (Tim-3 and PD-1), whereas paclitaxel alone evidently increased CTLA-4 expression (83). This evidence concerns the gene PDCD1 and neoplasm.